Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells.

Prima V, Kaliberova LN, Kaliberov S, Curiel DT, Kusmartsev S.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1117-1122. doi: 10.1073/pnas.1612920114. Epub 2017 Jan 17.

2.

Calcium Oxalate Stone Fragment and Crystal Phagocytosis by Human Macrophages.

Kusmartsev S, Dominguez-Gutierrez PR, Canales BK, Bird VG, Vieweg J, Khan SR.

J Urol. 2016 Apr;195(4 Pt 1):1143-51. doi: 10.1016/j.juro.2015.11.048. Epub 2015 Nov 26.

3.

Expansion of CCR8(+) inflammatory myeloid cells in cancer patients with urothelial and renal carcinomas.

Eruslanov E, Stoffs T, Kim WJ, Daurkin I, Gilbert SM, Su LM, Vieweg J, Daaka Y, Kusmartsev S.

Clin Cancer Res. 2013 Apr 1;19(7):1670-80. doi: 10.1158/1078-0432.CCR-12-2091. Epub 2013 Jan 30.

5.

Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway.

Daurkin I, Eruslanov E, Stoffs T, Perrin GQ, Algood C, Gilbert SM, Rosser CJ, Su LM, Vieweg J, Kusmartsev S.

Cancer Res. 2011 Oct 15;71(20):6400-9. doi: 10.1158/0008-5472.CAN-11-1261. Epub 2011 Sep 7.

6.

Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer.

Eruslanov E, Neuberger M, Daurkin I, Perrin GQ, Algood C, Dahm P, Rosser C, Vieweg J, Gilbert SM, Kusmartsev S.

Int J Cancer. 2012 Mar 1;130(5):1109-19. doi: 10.1002/ijc.26123. Epub 2011 Jun 21.

7.

Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells.

Eruslanov E, Daurkin I, Vieweg J, Daaka Y, Kusmartsev S.

Int Immunopharmacol. 2011 Jul;11(7):848-55. doi: 10.1016/j.intimp.2011.01.033. Epub 2011 Feb 11.

8.

Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.

Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S.

J Leukoc Biol. 2010 Nov;88(5):839-48. doi: 10.1189/jlb.1209821. Epub 2010 Jun 29.

PMID:
20587738
9.

Identification of ROS using oxidized DCFDA and flow-cytometry.

Eruslanov E, Kusmartsev S.

Methods Mol Biol. 2010;594:57-72. doi: 10.1007/978-1-60761-411-1_4.

PMID:
20072909
10.

Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.

Kaliberova LN, Kusmartsev SA, Krendelchtchikova V, Stockard CR, Grizzle WE, Buchsbaum DJ, Kaliberov SA.

Mol Cancer Ther. 2009 Nov;8(11):3130-9. doi: 10.1158/1535-7163.MCT-09-0270. Epub 2009 Nov 3.

11.

Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine.

Daurkin I, Eruslanov E, Vieweg J, Kusmartsev S.

Cancer Immunol Immunother. 2010 May;59(5):697-706. doi: 10.1007/s00262-009-0786-4. Epub 2009 Oct 31.

PMID:
19882154
12.

Enhancing the efficacy of cancer vaccines in urologic oncology: new directions.

Kusmartsev S, Vieweg J.

Nat Rev Urol. 2009 Oct;6(10):540-9. doi: 10.1038/nrurol.2009.177. Epub 2009 Sep 8. Review.

PMID:
19736551
13.

Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth.

Porvasnik S, Sakamoto N, Kusmartsev S, Eruslanov E, Kim WJ, Cao W, Urbanek C, Wong D, Goodison S, Rosser CJ.

Prostate. 2009 Sep 15;69(13):1460-9. doi: 10.1002/pros.21008.

PMID:
19588526
14.

Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer.

Eruslanov E, Kaliberov S, Daurkin I, Kaliberova L, Buchsbaum D, Vieweg J, Kusmartsev S.

J Immunol. 2009 Jun 15;182(12):7548-57. doi: 10.4049/jimmunol.0802358.

15.

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.

Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E, Padhya T, McCaffrey TV, McCaffrey JC, Gabrilovich DI.

J Immunol. 2009 May 1;182(9):5693-701. doi: 10.4049/jimmunol.0900092.

16.

Bcl-2 mediated modulation of vascularization in prostate cancer xenografts.

Sakai Y, Goodison S, Kusmartsev S, Fletcher B, Eruslanov E, Cao W, Porvasnik S, Namiki K, Anai S, Rosser CJ.

Prostate. 2009 Apr 1;69(5):459-70. doi: 10.1002/pros.20888.

PMID:
19107861
17.

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma.

Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Kübler H, Yancey D, Dahm P, Vieweg J.

Clin Cancer Res. 2008 Dec 15;14(24):8270-8. doi: 10.1158/1078-0432.CCR-08-0165.

18.

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.

Kusmartsev S, Eruslanov E, Kübler H, Tseng T, Sakai Y, Su Z, Kaliberov S, Heiser A, Rosser C, Dahm P, Siemann D, Vieweg J.

J Immunol. 2008 Jul 1;181(1):346-53.

19.

Reversal of tumor-mediated immunosuppression.

Vieweg J, Su Z, Dahm P, Kusmartsev S.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):727s-732s. Review.

20.
21.

Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells.

Kusmartsev S, Nagaraj S, Gabrilovich DI.

J Immunol. 2005 Oct 1;175(7):4583-92.

22.

Role of immature myeloid cells in mechanisms of immune evasion in cancer.

Kusmartsev S, Gabrilovich DI.

Cancer Immunol Immunother. 2006 Mar;55(3):237-45. Epub 2005 Jul 27. Review.

23.

STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion.

Kusmartsev S, Gabrilovich DI.

J Immunol. 2005 Apr 15;174(8):4880-91.

24.

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI.

J Immunol. 2004 Jan 15;172(2):989-99. Erratum in: J Immunol. 2004 Apr 1;172(7):4647.

25.

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, Salup R, Jove R, Gabrilovich D.

J Immunol. 2004 Jan 1;172(1):464-74.

26.

Effect of individual and combination treatment with cytokines on expression of sialoadhesin by bone marrow macrophages.

Kusmartsev SA, Danilets MG, Bel'skaya NV, Agafonov VI, Dygai AM, Gol'dberg ED.

Bull Exp Biol Med. 2003 Aug;136(2):139-41.

PMID:
14631493
27.

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, Gabrilovich D.

Cancer Res. 2003 Aug 1;63(15):4441-9.

28.

Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species.

Kusmartsev S, Gabrilovich DI.

J Leukoc Biol. 2003 Aug;74(2):186-96.

PMID:
12885935
29.

Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer.

Yu B, Kusmartsev S, Cheng F, Paolini M, Nefedova Y, Sotomayor E, Gabrilovich D.

Clin Cancer Res. 2003 Jan;9(1):285-94.

30.

Immature myeloid cells and cancer-associated immune suppression.

Kusmartsev S, Gabrilovich DI.

Cancer Immunol Immunother. 2002 Aug;51(6):293-8. Epub 2002 Apr 24. Review.

PMID:
12111117
31.
32.

[The role of interferon-gamma in the regulation of antiproliferative activity of nonadherent bone marrow cells].

Bel'skiĭ IuP, Danilets MG, Bel'skaia NV, Stal'bovskaia ES, Kusmartsev SA.

Biull Eksp Biol Med. 1999 Dec;128(12):677-80. Russian. No abstract available.

PMID:
10650472
33.

[Functional reserves of the pool of committed bone marrow hematopoietic precursors in AKR/JY mice during preleukemic period].

Khlusov IA, Kosnyreva LA, Kusmartsev SA, Dygaĭ AM, Gol'dberg ED.

Biull Eksp Biol Med. 1999 Nov;128(11):578-81. Russian. No abstract available.

PMID:
10640252
34.

Sialoadhesin expression by bone marrow macrophages derived from Ehrlich-tumor-bearing mice.

Kusmartsev S, Ruiz de Morales JM, Rullas J, Danilets MG, Subiza JL.

Cancer Immunol Immunother. 1999 Dec;48(9):493-8.

PMID:
10602886
35.

[Mechanisms of preleukemic hypoplasia of bone marrow erythroid stem cells in mice AKR/JY].

Gol'dberg ED, Bel'skiĭ IuP, Danilets MG, Dygaĭ AM, Kosnyreva LA, Kusmartsev SA, Khlusov IA.

Biull Eksp Biol Med. 1999 Jun;127(6):633-5. Russian. No abstract available.

PMID:
10445126
36.

[Suppressor and antineoplastic activity of the bone marrow and spleen cells in aging AKR mice].

Bel'skiĭ IuP, Bel'skaia NV, Danilets MG, Stal'bovskaia ES, Kusmartsev SA.

Biull Eksp Biol Med. 1999 Apr;127(4):452-4. Russian. No abstract available.

PMID:
10367135
37.

[Adaptive potential of granulocytic stem cells in the bone marrow from preleukemic AKR mice].

Gol'dberg ED, Bel'skiĭ IuP, Danilets MG, Dygaĭ AM, Kosnyreva LA, Kusmartsev SA, Khlusov IA.

Biull Eksp Biol Med. 1999 Feb;127(2):151-4. Russian. No abstract available.

PMID:
10095942
38.

Immunosuppressive cells in bone marrow of patients with stomach cancer.

Kusmartsev SA, Kusmartseva IN, Afanasyev SG, Cherdyntseva NV.

Adv Exp Med Biol. 1998;451:189-94. No abstract available.

PMID:
10026871
39.

[Expression of the bone marrow macrophage receptors during cytostatic myelosuppression].

Gol'dberg ED, Bel'skiĭ IuP, Danilets MG, Dygaĭ AM, Zhdanov VV, Kusmartsev SA.

Biull Eksp Biol Med. 1998 Jul;126(7):25-7. Russian. No abstract available.

PMID:
9777188
40.

[Structure-functional organization of the bone marrow in dynamics of aging of AKR/J mice].

Gol'dberg ED, Bel'skiĭ IuP, Danilets MG, Dygaĭ AM, Kosnyreva LA, Kusmartsev SA, Khlusov IA.

Biull Eksp Biol Med. 1998 Mar;125(3):266-8. Russian. No abstract available.

PMID:
9606539
41.

[Suppressor activity of bone marrow cells in patients with stomach neoplasms. Effect of prostaglandins, growth transforming factor-beta, and nitric oxide].

Kusmartseva IN, Afanas'ev SG, Cherdyntseva NV, Kondakova IV, Kusmartsev SA.

Biull Eksp Biol Med. 1998 Feb;125(2):217-20. Russian. No abstract available.

PMID:
9559142
42.

[Differential induction of natural suppressor activity of bone marrow cells in vitro by various types of tumors].

Bel'skiĭ IuP, Zemlianskaia NV, Kusmartsev SA, Agranovich IM.

Biull Eksp Biol Med. 1995 Aug;120(8):184-7. Russian. No abstract available.

PMID:
7579281
43.

[The possible glyciram stimulation of bone marrow hematopoiesis under cytostatic blood depression].

Dygaĭ AM, Zhdanov VV, Khlusov IA, Liubavina PA, Novitskiĭ EV, Kusmartsev SA, Gol'dberg ED.

Eksp Klin Farmakol. 1995 Mar-Apr;58(2):40-2. Russian.

PMID:
7773088
44.

[Reduced antitumoral and suppressor activity of nonadherent bone marrow cells during culturing in a mixture with supernatant of Ehrlich tumor].

Bel'skiĭ IuP, Agranovich IM, Kusmartsev SA.

Biull Eksp Biol Med. 1994 May;117(5):514-7. Russian. No abstract available.

PMID:
9296706
45.

[The effect of cells presenting the erythroblast antigen on the natural suppressor activity of nonadhesive bone marrow cells].

Kusmartsev SA, Agranovich IM, Bel'skiĭ IuP, Goncharskaia MA.

Biull Eksp Biol Med. 1993 Jun;115(6):652-4. Russian.

PMID:
8374150
46.
47.

[The activity of nonspecific bone marrow and spleen suppressors in the latent period of tumor growth].

Ogreba VI, Kusmartsev SA, Vasil'ev NV.

Vopr Onkol. 1988;34(8):952-5. Russian.

PMID:
2971291

Supplemental Content

Loading ...
Support Center